Jove
Visualize
Contact Us

Related Experiment Videos

Niacin as a potential AIDS preventive factor.

M F Murray1

  • 1Tewksbury Hospital, Department of Medicine, MA 01876, USA. docsmurr@massmed.org

Medical Hypotheses
|January 1, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictive value of genomic screening: cross-sectional study of cystic fibrosis in 50,788 electronic health records.

NPJ genomic medicine·2019
Same author

Are physicians prepared for whole genome sequencing? a qualitative analysis.

Clinical genetics·2015
Same author

Clinical picture: Multicolour karyotyping.

Lancet (London, England)·2001
Same author

Increased plasma tryptophan in HIV-infected patients treated with pharmacologic doses of nicotinamide.

Nutrition (Burbank, Los Angeles County, Calif.)·2001
Same author

Coping with change: 5. Self-talk.

Hospital practice (1995)·2000
Same author

Coping with change: 4. Clear definitions and creative solutions.

Hospital practice (1995)·2000
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Human immunodeficiency virus (HIV) infection may cause niacin depletion. Supplementing with niacin, a B vitamin, could potentially serve as an AIDS preventive factor, especially for those unable to afford antiretroviral therapy.

Area of Science:

  • Biochemistry
  • Immunology
  • Nutritional Science

Background:

  • Patients with Acquired Immunodeficiency Syndrome (AIDS) exhibit findings consistent with niacin depletion.
  • Clinical and laboratory data suggest potential benefits of niacin in managing Human Immunodeficiency Virus (HIV) infection.
  • HIV infection leads to significant metabolic disruption due to high viral production rates.

Purpose of the Study:

  • To hypothesize that HIV infection induces niacin depletion.
  • To propose therapeutic niacin as a potential secondary AIDS preventive factor.
  • To explore cost-effective strategies for managing metabolic disruption in HIV-infected individuals.

Main Methods:

  • Review of existing clinical and laboratory data on niacin depletion in AIDS patients.

Related Experiment Videos

  • Hypothetical model linking HIV infection, niacin depletion, and AIDS prevention.
  • Literature review on niacin's role as a 'pellagra preventive factor'.

    • Main Results:

    • Niacin depletion is a recognized issue in AIDS patients.
    • Niacin has demonstrated potential benefits in HIV infection contexts.
    • Therapeutic niacin is proposed as an accessible secondary AIDS preventive strategy.

    Conclusions:

    • HIV infection is hypothesized to cause niacin depletion.
    • Niacin supplementation may act as an AIDS preventive factor.
    • Niacin offers a potential complementary strategy to antiretroviral therapy for HIV management.